News tagged with leukemia cells
Therapy targets leukemia stem cells
New research takes aim at stubborn cancer stem cells that are thought to be responsible for treatment resistance and relapse. The study, published by Cell Press in the February 14 issue of the journal Cancer Cell, provid ...
30 minutes ago |
5 / 5 (1) |
0
Researchers discover the processes leading to acute myeloid leukemia
Researchers at UC Santa Barbara have discovered a molecular pathway that may explain how a particularly deadly form of cancer develops. The discovery may lead to new cancer therapies that reprogram cells instead ...
Jan 30, 2012 |
5 / 5 (1) |
0
|
Study finds leukemia cells are 'bad to the bone'
University of Rochester Medical Center researchers have discovered new links between leukemia cells and cells involved in bone formation, offering a fresh perspective on how the blood cancer progresses and raising the possibility ...
Jan 26, 2012 |
5 / 5 (3) |
0
|
Study pinpoints and plugs mechanism of AML cancer cell escape
A study published this week in the journal Leukemia identifies a mechanism that acute myeloid leukemia (AML) cells use to evade chemotherapy – and details how to close this escape route.
Jan 18, 2012 |
5 / 5 (2) |
0
New culprit discovered in T-cell acute lymphoblastic leukemia
A new study published in the journal Nature Medicine by NYU Cancer Institute researchers, shows how the cancer causing gene Notch, in combination with a mutated Polycomb Repressive Complex 2 (PRC2) protein complex, work t ...
Jan 12, 2012 |
5 / 5 (2) |
0
|
Chemotherapy may influence leukemia relapse: research
The chemotherapy drugs required to push a common form of adult leukemia into remission may contribute to DNA damage that can lead to a relapse of the disease in some patients, findings of a new study suggest.
Jan 11, 2012 |
5 / 5 (2) |
0
|
Fish oil may hold key to leukemia cure
A compound produced from fish oil that appears to target leukemia stem cells could lead to a cure for the disease, according to Penn State researchers. The compound -- delta-12-protaglandin J3, or D12-PGJ3 ...
Dec 22, 2011 |
5 / 5 (16) |
1
|
First comprehensive DNA study of mast cell leukemia uncovers clues that could improve therapy
Cancer researchers at Cold Spring Harbor Laboratory (CSHL) have carried out the first comprehensive study of the changes seen in the DNA of a patient with mast cell leukemia (MCL), an extremely aggressive subtype of acute ...
Dec 16, 2011 |
5 / 5 (1) |
0
|
No higher risk of acute leukaemia in close relatives
(Medical Xpress) -- Parents, siblings and children of patients with the most common form of acute leukemia do not run a higher risk of developing the disease as was once believed, according to a new study from the Swedish ...
Dec 15, 2011 |
5 / 5 (2) |
0
|
Prognostic model developed for MDS related to prior cancer therapy
A large-scale analysis of patients whose myelodysplastic syndrome is related to earlier cancer treatment overturns the notion that all of them have a poor prognosis, researchers from The University of Texas MD Anderson Cancer ...
Dec 13, 2011 |
not rated yet |
0
AML patients have high response rate with vorinostat added to treatment
Adding a drug that activates genes to frontline combination therapy for acute myeloid leukemia resulted in an 85 percent remission rate after initial treatment, researchers at The University of Texas MD Anderson Cancer Center ...
Dec 13, 2011 |
not rated yet |
0
Gene mutation signals a high risk of recurrence in some older acute-leukemia patients
Older people with acute myeloid leukemia and normal looking chromosomes in their cancer cells have a higher risk of recurrence if they have mutations in a gene called ASXL1, according to a new study by researchers at the ...
Dec 12, 2011 |
not rated yet |
0
Two-faced leukemia?
One kind of leukemia sometimes masquerades as another, according to a study published online this week in the Journal of Experimental Medicine.
Dec 12, 2011 |
5 / 5 (4) |
0
Ruxolinitib better at reducing myelofibrosis symptoms, study shows
In a major advance in treatment, a multicenter study found that ruxolinitib did a better job than off-label chemotherapy drugs reducing the terrible symptoms associated with myelofibrosis, including pain, enlarged spleen, anemia, fever, chills ...
Dec 12, 2011 |
not rated yet |
0
Novel export-inhibitor shows promise for treating chronic lymphocytic leukemia
An experimental drug that works by blocking the export of key control molecules from the nucleus of cancer cells shows promise as a treatment for chronic lymphocytic leukemia (CLL) and other incurable B-cell malignancies, ...
Dec 12, 2011 |
5 / 5 (2) |
0
